OnCore Biopharma

OnCore Biopharma is a privately held biotechnology company focused on the research, development, and commercialization of therapies for treating chronic hepatitis B virus (HBV) infection. OnCore has assembled a portfolio of novel candidate products with unique mechanisms of action for the treatment of hepatitis B and is committed to providing therapeutic solutions.